CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 30 enrolled
Drug / intervention
parasacral transcutaneous electrical nerve stimulation (PTENS) +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04570605
NCT04570605N/ACompleted

Feasibility of Home Parasacral Transcutaneous Electrical Nerve Stimulation (PTENS) for the Voiding Dysfunction in the Pediatric Population: A Pilot Study

University of Utah·interventional·Posted Sep 30, 2020·Updated Mar 17, 2022

In Brief

A clinical study evaluating parasacral transcutaneous electrical nerve stimulation (PTENS) and Standard Urotherapy for Overactive Bladder and 2 related conditions. Completed, enrolled 30 participants across 1 site.

Detailed Summary

Pilot study for determining feasibility of home parasacral transcutaneous electrical nerve stimulation in treatment of urinary urgency and incontinence.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedSep 30, 2020
Enrollment StartApr 1, 2019
Primary CompletionJun 1, 2020
Study CompletionJul 1, 2020
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 5.8 years ago

Interventions

parasacral transcutaneous electrical nerve stimulation (PTENS)device

electrode patches placed on skin of lower back just above each side of the gluteal cleft (parasacral) and attached to TENS unit at specific settings three times a week for 30 minutes for 12 weeks.

Standard Urotherapyother

standard behavioral therapy recommendations including timed voiding, fluid intake recommendations and bowel management recommendations including videos instructing patients and parents on these issues. This is current standard of care.